ENSEM Therapeutics

company

About

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$67M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active

ENSEM Therapeutics is a pioneering drug discovery and development company that leverages its unique Kinetic EnsembleTM platform to develop innovative small-molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$67M
ENSEM Therapeutics has raised a total of $67M in funding over 2 rounds. Their latest funding was raised on Apr 6, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 6, 2022 Series A $67M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
ENSEM Therapeutics is funded by 2 investors. Cenova Capital and Pavilion Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Cenova Capital Series A
Pavilion Capital Series A